Alternative Conversion Methods for Transition Probabilities in State-Transition Models: Validity and Impact on Comparative Effectiveness and Cost-Effectiveness

被引:1
|
作者
Jahn, Beate [1 ]
Kurzthaler, Christina [1 ,2 ]
Chhatwal, Jagpreet [3 ,4 ]
Elbasha, Elamin H. [5 ]
Conrads-Frank, Annette [1 ]
Rochau, Ursula [1 ]
Sroczynski, Gaby [1 ]
Urach, Christoph [6 ]
Bundo, Marvin [1 ]
Popper, Niki [6 ,7 ,8 ]
Siebert, Uwe [1 ,3 ,4 ,9 ]
机构
[1] UMIT Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & Hlth Technol As, Dept Publ Hlth Hlth Serv Res & Hlth Technol Asses, Hall In Tirol, Austria
[2] Univ Innsbruck, Inst Theoret Phys, Innsbruck, Austria
[3] Harvard Med Sch, Inst Technol Assessment, Massachusetts Gen Hosp, Boston, MA 02115 USA
[4] Harvard Med Sch, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA
[5] Merck & Co Inc, Kenilworth, NJ USA
[6] Dwh GmbH Simulat Serv & Tech Solut, Vienna, Austria
[7] Tech Univ, Inst Anal & Sci Comp, Vienna, Austria
[8] DEXHELPP Decis Support Hlth Policy & Planning, Vienna, Austria
[9] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA USA
关键词
conversion transition probability; cost-effectiveness analysis; markov model; markov transition matrix; state-transition model; MARKOV-CHAIN; MATRICES; RATES;
D O I
10.1177/0272989X19851095
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background. In state-transition models (STMs), decision problems are conceptualized using health states and transitions among those health states after predefined time cycles. The naive, commonly applied method (C) for cycle length conversion transforms all transition probabilities separately. In STMs with more than 2 health states, this method is not accurate. Therefore, we aim to describe and compare the performance of method C with that of alternative matrix transformation methods. Design. We compare 2 alternative matrix transformation methods (Eigenvalue method [E], Schure-Pade method [SP]) to method C applied in an STM of 3 different treatment strategies for women with breast cancer. We convert the given annual transition matrix into a monthly-cycle matrix and evaluate induced transformation errors for the transition matrices and the long-term outcomes: life years, quality-adjusted life-years, costs and incremental cost-effectiveness ratios, and the performance related to the decisions. In addition, we applied these transformation methods to randomly generated annual transition matrices with 4, 7, 10, and 20 health states. Results. In theory, there is no generally applicable correct transformation method. Based on our simulations, SP resulted in the smallest transformation-induced discrepancies for generated annual transition matrices for 2 treatment strategies. E showed slightly smaller discrepancies than SP in the strategy, where one of the direct transitions between health states was excluded. For long-term outcomes, the largest discrepancy occurred for estimated costs applying method C. For higher dimensional models, E performs best. Conclusions. In our modeling examples, matrix transformations (E, SP) perform better than transforming all transition probabilities separately (C). Transition probabilities based on alternative conversion methods should therefore be applied in sensitivity analyses.
引用
收藏
页码:509 / 522
页数:14
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF POPULATION SCREENING FOR HAEMOCHROMATOSIS IN AUSTRALIA: A STATE-TRANSITION MODEL
    de Graaff, B. L.
    Si, L.
    Neil, A.
    Yee, K. C.
    Sanderson, K.
    Gurrin, L. C.
    Palmer, A. J.
    VALUE IN HEALTH, 2016, 19 (07) : A874 - A875
  • [2] An Introductory Tutorial on Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example
    Alarid-Escudero, Fernando
    Krijkamp, Eline
    Enns, Eva A.
    Yang, Alan
    Hunink, M. G. Myriam
    Pechlivanoglou, Petros
    Jalal, Hawre
    MEDICAL DECISION MAKING, 2023, 43 (01) : 3 - 20
  • [3] Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model
    L. Si
    T. M. Winzenberg
    Q. Jiang
    A. J. Palmer
    Osteoporosis International, 2015, 26 : 1477 - 1489
  • [4] Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model
    Si, L.
    Winzenberg, T. M.
    Jiang, Q.
    Palmer, A. J.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (05) : 1477 - 1489
  • [5] A Tutorial on Time-Dependent Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example
    Alarid-Escudero, Fernando
    Krijkamp, Eline
    Enns, Eva A.
    Yang, Alan
    Hunink, M. G. Myriam
    Pechlivanoglou, Petros
    Jalal, Hawre
    MEDICAL DECISION MAKING, 2023, 43 (01) : 21 - 41
  • [6] ESTIMATING TRANSITION PROBABILITIES FROM PUBLISHED ONCOLOGY SURVIVAL DATA: COMPARISON OF METHODS AND IMPACT ON COST-EFFECTIVENESS
    Cupples, G.
    Krebs, E.
    Regier, D.
    VALUE IN HEALTH, 2024, 27 (12) : S619 - S619
  • [7] Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model
    de Graaff B.
    Si L.
    Neil A.L.
    Yee K.C.
    Sanderson K.
    Gurrin L.C.
    Palmer A.J.
    PharmacoEconomics - Open, 2017, 1 (1) : 37 - 51
  • [8] Adding noise to Markov cohort state-transition model in decision modeling and cost-effectiveness analysis
    Iskandar, Rowan
    STATISTICS IN MEDICINE, 2020, 39 (10) : 1529 - 1540
  • [9] ESTIMATION OF TRANSITION PROBABILITIES FOR STATE-TRANSITION MODELS: A REVIEW OF NICE APPRAISALS
    Srivastava, T.
    Latimer, N. R.
    Tappenden, P.
    VALUE IN HEALTH, 2020, 23 : S615 - S616
  • [10] Estimation of Transition Probabilities for State-Transition Models: A Review of NICE Appraisals
    Tushar Srivastava
    Nicholas R. Latimer
    Paul Tappenden
    PharmacoEconomics, 2021, 39 : 869 - 878